Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Pharyngeal electrical stimulation for dysphagia associated with multiple sclerosis: A pilot study.
The utility of the Six-Spot Step Test as a measure of walking performance in ambulatory individuals with Multiple Sclerosis across the disability spectrum.
Retinal nerve fibre layer thinning in patients with clinically isolated optic neuritis and early treatment with interferon-Beta.
Regulation of myelination in the Central Nervous System by Nuclear Lamin B1 and non-coding RNAs.
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters.
Basal Ganglia Iron in Patients with Multiple Sclerosis Measured with 7T Quantitative Susceptibility Mapping Correlates with Inhibitory Control.
Cost-effectiveness analysis of interferon Beta-1b for the treatment of patients with a first clinical event suggestive of multiple sclerosis.
Hematopoietic Stem Cell Therapy for Multiple Sclerosis: Top 10 Lessons Learned.
[Laquinimod is an oral drug with a marked neuroprotective effect for pathogenetic treatment of multiple sclerosis(review)].
Expansion of CD27(high) plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation.
Mind-body medicine for multiple sclerosis: a systematic review.
A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease.
Oligodendrocyte Precursor Cell-Intrinsic Effect of Rheb1 Controls Differentiation and Mediates mTORC1-Dependent Myelination in Brain.
Structural Brain MR Imaging Changes Associated with Obsessive-Compulsive Disorder in Patients with Multiple Sclerosis.
Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
The spectrum of post-vaccination inflammatory CNS demyelinating syndromes.
The effect of scheduled antibody testing on treatment patterns in interferon-treated patients with multiple sclerosis.
Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures.
Emotional and neutral verbal memory impairment in Multiple Sclerosis.
OLFACTORY ENSHEATHING GLIA CELL THERAPY AND TUBULAR CONDUIT ENHANCE NERVE REGENERATION AFTER MOUSE SCIATIC NERVE TRANSECTION.
Metabolite changes in radiologically isolated syndrome: More pathology than meets the eye?
Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States.
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.
Expression and isotopic labelling of the potassium channel blocker ShK toxin as a thioredoxin fusion protein in bacteria.
Anti-CD25 Immunotherapy: Regulating the Regulators.
Pages
« first
‹ previous
…
246
247
248
249
250
251
252
253
254
…
next ›
last »